Attenuation of virus-induced airway dysfunction in rats treated with imiquimod

European Respiratory Journal

Volumn 11, Issue 2, 1998, Pages 324-329

  Stokes, J R ^a   Sorkness, R L ^b,e   Kaplan, M R ^a   Castleman, W L ^c   Tomai, M A ^d   Miller, R L ^d   Lemanske Jr, R F ^a  

^a St Luke's Sinai Samaritan Med C   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d 3M COMPANY   (United States)

^e University of Wisconsin Health   (United States)

Author keywords

Asthma; Cytokines; Interferon ; Parainfluenza; Rats; Sendai virus

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; IMIQUIMOD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHIL; INFLAMMATORY CELL; LEUKOCYTE; LEUKOCYTE COUNT; LUNG; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; RNA VIRUS INFECTION; SENDAI VIRUS;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; INFLAMMATION; INTERFERONS; MALE; RATS; RESPIRATORY TRACT DISEASES; RESPIROVIRUS; RESPIROVIRUS INFECTIONS;

EID: 0031910959     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11020324     Document Type: Article

References (35)

1. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22: 325-336.
2. Cypcar D, Stark J, Lemanske RF Jr. The impact of respiratory infections on asthma. Pediatr Clin N Amer 1992; 39: 1259-1276.
3. Bellanti JA, Kadlec JV, Escobar-Gutierrez A. Cytokines and the immune response. Pediatr Clin N Amer 1994; 41: 597-621.
4. Bernstein DI, Harrison CJ. Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother 1989; 33: 1511-1515.
5. Harrison CJ, Miller RL, Bernstein DI. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother 1994; 38: 2059-2064.
6. Harrison CJ, Jenski L, Voychehovski T, Bernstein DI. Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection. Antiviral Res 1988; 10: 209-224.
7. Bernstein DI, Miller RL, Harrison CJ. Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development. Antiviral Res 1993; 20: 45-55.
8. Chen M, Griffith BP, Lucia HL, Hsiung GD. Efficacy of S26308 against guinea-pig cytomegalovirus infection. Antimicrob Agents Chemother 1988; 32: 678-683.
9. Kende M, Lupton HW, Canonico PG. Treatment of experimental viral infarctions with immunomodulators. Adv Biosc 1988; 68: 51-63.
10. Sidky YA, Borden EC, Weeks CE, Reiter MJ, Hatcher JF, Bryan GT. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res 1992; 52: 3528-3533.
11. Weeks CE, Gibson SJ. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolise R-842 in human blood cells in vitro. J Interferon Res 1994; 14: 81-85.
12. Megyeri K, Au W, Rosztoczy I, et al. Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by sendai virus utilize similar signal transduction pathways. Mol Cell Biol 1995; 15: 2207-2218.
13. Reiter MJ, Testerman TL, Miller RL, Weeks CE, Tomai MA. Cytokine induction in mice by the immunomodulator imiquimod. J Leukoc Biol 1994; 55: 234-240.
14. Gibson SJ, Imbertson LM, Wagner TL, et al. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res 1995; 15: 537-545.
15. Testerman TL, Gerster JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365-372.
16. Gibson SJ, Elrod SV, Miller RL, Weeks CE. Oral R-837 induces alpha interferon in cynomolgus monkeys. J Interferon Res 1990; 10: S124.
17. Witt PL, Ritch PS, Reding D, et al. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. Cancer Res 1993; 53: 5176-5180.
18. Castleman WL, Brundage-Anguish LJ, Kreitzer L, Neuenschwander SB. Pathogenesis or bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (sendai) virus. Am J Pathol 1987; 129: 277-286.
19. Sorkness R, Clough JJ, Castleman WL, Lemanske RF Jr. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am J Respir Crit Care Med 1994; 150: 28-34.
20. Sorkness R, Lemanske RF Jr, Castleman WL. Persistent airway hyperresponsiveness after neonatal viral bronchiolitis in rats. J Appl Physiol 1991; 70: 375-383.
21. Sheth KK, Sorkness RL, Clough JJ, McAllister PK, Castleman WL, Lemanske RF Jr. Reversal of persistent post-bronchiolitis airway abnormalities with dexamethasone in rats. J Appl Physiol 1994; 76: 333-338.
22. Brennan GI, Kronenburg LH. Automated bioassay of interferons in microtest plates. Biotechniques 1983; 1: 78-82.
23. Sorkness R, Lemanske RF Jr. Attenuation of airway hyperresponsiveness during acute viral infection using the 21-aminosteroid U-83836E in rats. Pulm Pharm 1996; 9: 219-222.
24. Varner AK, Sorkness RL, Kumar A, et al. Effects of Imiquimod on post-viral asthma-like syndrome in BN rats. J Allergy Clin Immunol 1997; 99: S127.
25. Miller RL, Birmachu W, Gerster JF, et al. Imiquimod: cytokine induction and antiviral activity. International Antiviral News 1995; 3: 111.
26. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opinion Immunol 1994; 6: 838-846.
27. Brinkmann V, Geigar T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 1993; 178: 1655-1663.
28. Parronchi P, De Carli M, Manetti R, et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992; 149: 2977-2983.
29. Finkelman FD, Svetic A, Gresser I, et al. Regulation by interferon a of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 1991; 174: 1179-1188.
30. Tang Y, Graham BS. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T-lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 1994; 94: 1953-1958.
31. Glyllenhammar H, Hafstrom I, Ringertz B, Uden A, Palmblad J. Recombinant human leukocyte interferon modulates neutrophil function in vitro. J Interferon Res 1988; 8: 441-449.
32. Nakajima H, Nakao A, Watanabe Y, Yoshida S, Iwamoto I. IFN-α inhibits antigen-induced eosinophils and CD4+ T-cell recruitment into tissue. J Immunol 1994; 153: 1264-1270.
33. Aldebert D, Lamkioued B, Desaint C, et al. Eosinophils express a functional receptor for interferon a: Inhibitory role of interferon a on the release of mediators. Blood 1996; 87: 2354-2360.
34. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
35. Schandene L, Del Prete GF, Cogan E, et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 1996; 97: 309-315.